Coronary artery disease
Conditions
Interventions
Non-calcified coronary artery atherosclerotic lesions (calcification <
50% of circumference) predilated with semi-compliant conventional balloon followed by a single 2.5-3.0 mm Cobalt-chromium Everolimus-eluting stent deployment under optical coherent tomography (OCT) gu
50% of circumference) predilated with semi-compliant Scoring balloon followed by a single 2.5-3.0 mm Cobalt-chromium Everolimus-eluting stent deployment under optical coherent tomography (OCT) guidanc
Sponsors
Nishiarai Heart Center Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Consecutive patients undergoing staged PCI in a single cardiovascular center. (i) Referential vessel diameter estimated by OCT ((prox.+dist.)/2): 2.5-3.0 mm (ii) Lesion that is able to be covered by a single stent (iii) Lesion with calcification less than 50% of circumference
Exclusion criteria
Exclusion criteria: (i) Acute coronary syndrome (ii) Pregnant patients (iii) Patients with malignant neoplasm whose life expectancies of less than 6 months (iv) Patients underwent prior PCI/CABG within 6 months (v) Patients with decompensated heart failure (vi) Patients with chronic kidney disease > stage 4 (vii) Patients with allergic reaction against ASA or clopidogrel
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of achieved to predicted stent area after deployment measured by optical coherent tomography (OCT) | — |
Secondary
| Measure | Time frame |
|---|---|
| i) Binary stent restenosis at remote phase (QCA) ii) Target vessel diameter/area after balloon angioplasty (OCT) iii) All-cause mortality, MACE (Major Adverse Cardiac Event) | — |
Countries
Japan
Contacts
Public ContactKentaro Jujo
Nishiarai Heart Center Hospital Department of Cardiology
Outcome results
None listed